Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6834331rdf:typepubmed:Citationlld:pubmed
pubmed-article:6834331lifeskim:mentionsumls-concept:C0330390lld:lifeskim
pubmed-article:6834331lifeskim:mentionsumls-concept:C0699762lld:lifeskim
pubmed-article:6834331lifeskim:mentionsumls-concept:C0521387lld:lifeskim
pubmed-article:6834331lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:6834331lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:6834331pubmed:issue2lld:pubmed
pubmed-article:6834331pubmed:dateCreated1983-5-5lld:pubmed
pubmed-article:6834331pubmed:abstractTextSpontaneous intrauterine pressure cycles were abolished for periods of several hours in ovariectomized non-pregnant ewes within 8 h of an injection of 50 micrograms oestradiol-17 beta. Following the quiescent period, a phase of intense uterine activity ensued for several hours before again being replaced by several hours of quiescence. This active/inactive cycle disappeared after 2-4 days if further daily injections of oestradiol were not given. During the quiescent periods the uterus retained its responsiveness to oxytocin and PGF-2 alpha. Increasing the dose of oestradiol failed to prolong the periods of quiescence.lld:pubmed
pubmed-article:6834331pubmed:languageenglld:pubmed
pubmed-article:6834331pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6834331pubmed:citationSubsetIMlld:pubmed
pubmed-article:6834331pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6834331pubmed:statusMEDLINElld:pubmed
pubmed-article:6834331pubmed:monthMarlld:pubmed
pubmed-article:6834331pubmed:issn0022-4251lld:pubmed
pubmed-article:6834331pubmed:authorpubmed-author:PorterD GDGlld:pubmed
pubmed-article:6834331pubmed:authorpubmed-author:LyeS JSJlld:pubmed
pubmed-article:6834331pubmed:authorpubmed-author:WathesD CDClld:pubmed
pubmed-article:6834331pubmed:issnTypePrintlld:pubmed
pubmed-article:6834331pubmed:volume67lld:pubmed
pubmed-article:6834331pubmed:ownerNLMlld:pubmed
pubmed-article:6834331pubmed:authorsCompleteYlld:pubmed
pubmed-article:6834331pubmed:pagination335-41lld:pubmed
pubmed-article:6834331pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:6834331pubmed:meshHeadingpubmed-meshheading:6834331-...lld:pubmed
pubmed-article:6834331pubmed:meshHeadingpubmed-meshheading:6834331-...lld:pubmed
pubmed-article:6834331pubmed:meshHeadingpubmed-meshheading:6834331-...lld:pubmed
pubmed-article:6834331pubmed:meshHeadingpubmed-meshheading:6834331-...lld:pubmed
pubmed-article:6834331pubmed:meshHeadingpubmed-meshheading:6834331-...lld:pubmed
pubmed-article:6834331pubmed:meshHeadingpubmed-meshheading:6834331-...lld:pubmed
pubmed-article:6834331pubmed:meshHeadingpubmed-meshheading:6834331-...lld:pubmed
pubmed-article:6834331pubmed:meshHeadingpubmed-meshheading:6834331-...lld:pubmed
pubmed-article:6834331pubmed:year1983lld:pubmed
pubmed-article:6834331pubmed:articleTitleOestradiol-17 beta both inhibits and stimulates myometrial activity in ewes in vivo.lld:pubmed
pubmed-article:6834331pubmed:publicationTypeJournal Articlelld:pubmed